Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Down 35.9% in February

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) saw a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 18,020 shares, a decline of 35.9% from the February 12th total of 28,112 shares. Based on an average daily trading volume, of 79,625 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the company’s shares are short sold. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 79,625 shares, the short-interest ratio is presently 0.2 days.

Hedge Funds Weigh In On Xtant Medical

A number of large investors have recently modified their holdings of the company. Wiregrass Investment Management LLC acquired a new position in shares of Xtant Medical in the 4th quarter valued at about $81,000. Renaissance Technologies LLC increased its position in Xtant Medical by 28.8% during the 4th quarter. Renaissance Technologies LLC now owns 919,860 shares of the medical device company’s stock worth $721,000 after purchasing an additional 205,945 shares in the last quarter. Tradition Wealth Management LLC acquired a new stake in Xtant Medical during the 4th quarter worth approximately $79,000. Hillsdale Investment Management Inc. purchased a new position in Xtant Medical in the fourth quarter valued at approximately $284,000. Finally, Nano Cap New Millennium Growth Fund L P purchased a new position in Xtant Medical in the fourth quarter valued at approximately $220,000. 69.33% of the stock is currently owned by hedge funds and other institutional investors.

Xtant Medical Trading Up 2.9%

Shares of XTNT stock traded up $0.02 on Friday, reaching $0.62. 115,265 shares of the stock were exchanged, compared to its average volume of 96,265. The company has a quick ratio of 1.06, a current ratio of 2.21 and a debt-to-equity ratio of 0.35. The stock has a market cap of $86.94 million, a P/E ratio of 62.16 and a beta of -0.30. The firm has a 50 day moving average of $0.62 and a two-hundred day moving average of $0.67. Xtant Medical has a 1-year low of $0.34 and a 1-year high of $0.95.

About Xtant Medical

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.